These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 342230

  • 1. Drug-induced agranulocytosis.
    Pisciotta V.
    Drugs; 1978 Feb; 15(2):132-43. PubMed ID: 342230
    [Abstract] [Full Text] [Related]

  • 2. Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors.
    Pisciotta AV.
    Blood Rev; 1990 Dec; 4(4):226-37. PubMed ID: 2076470
    [Abstract] [Full Text] [Related]

  • 3. Immune and toxic mechanisms in drug-induced agranulocytosis.
    Pisciotta AV.
    Semin Hematol; 1973 Oct; 10(4):279-310. PubMed ID: 4139755
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms.
    Vincent PC.
    Drugs; 1986 Jan; 31(1):52-63. PubMed ID: 3940848
    [Abstract] [Full Text] [Related]

  • 6. [Chlorpromazine-induced agranulocytosis: a case report].
    Stephan F, Podlipski MA, Kerleau JM, Petit M, Guillin O.
    Encephale; 2009 Apr; 35(2):173-5. PubMed ID: 19393387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Agranulocytosis induced by certain phenothiazine derivatives.
    Pisciotta AV.
    JAMA; 1969 Jun 09; 208(10):1862-8. PubMed ID: 4890332
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies on agranulocytosis. IX. A biochemical defect in chlorpromazine-sensitive marrow cells.
    Pisciotta AV.
    J Lab Clin Med; 1971 Sep 09; 78(3):435-48. PubMed ID: 5092863
    [No Abstract] [Full Text] [Related]

  • 13. [Diagnostic difficulties in myeloblastic crisis during acute drug-induced agranulocytosis].
    Chmielińska A, Pawlak J, Zielińska E.
    Wiad Lek; 1976 Jan 15; 29(2):139-44. PubMed ID: 1062064
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Pyramidon-induced agranulocytosis: transient marrow aplasia of the three myeloid differentiation lines. Marrow recovery followed by secondary hypoplasia].
    Flandrin G, Daniel MT, Brière J, Varet B, Pestel M, Bernard J.
    Nouv Rev Fr Hematol; 1971 Jan 15; 11(2):219-31. PubMed ID: 4252675
    [No Abstract] [Full Text] [Related]

  • 18. Monocytosis in chlorpromazine-associated agranulocytosis. Ter mination in acute leukemia.
    Cassileth PA.
    Am J Med; 1967 Sep 15; 43(3):471-6. PubMed ID: 5231906
    [No Abstract] [Full Text] [Related]

  • 19. Haematological aspects of drug-induced agranulocytosis.
    Ruvidić R, Jelić S.
    Scand J Haematol; 1972 Sep 15; 9(1):18-27. PubMed ID: 5056478
    [No Abstract] [Full Text] [Related]

  • 20. Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis.
    Apinantriyo B, Lekhakula A, Rujirojindakul P.
    Hematology; 2011 Jan 15; 16(1):50-3. PubMed ID: 21269568
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.